Aligos Therapeutics ALGS 深 沪
已收盘 09-19 16:00:00 美东时间
10.18
-3.980
-28.11%
华盛通- 最 高13.105
- 今 开12.81
- 成交量 87.51万股
- 最 低 9.90
- 昨 收 14.16
- 总市值 3253.63万
- 52周最高 30.00
- 市盈率 静 --
- 换手率 27.38%
- 52周最低 8.705
- 委 比 0.00%
- 总股本 319.61万
- 历史最高 937.75
- 量 比 16.20
- 振 幅 22.63%
- 历史最低 8.705
- 每 手 1
- 风险率 3.92%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aligos Therapeutics shares are trading lower. The company announced results from its Phase 2a HERALD study.
Aligos Therapeutics shares are trading lower. The company announced results fro...
今天 03:13
Aligos posts initial mid-stage trial results for MASH candidate
Aligos Therapeutics (NASDAQ:ALGS) on Thursday shared topline results from a mid-stage study for its lead candidate ALG-055009 in patients suffering from a liver condition called metabolic-dysfunction-...
09-19 20:44
快讯 | aligos therapeutics宣布根据纳斯达克上市规则5635(C)(4)进行诱因授予。
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(...
09-13 20:00
Aligos Therapeutics Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-19 20:08
快讯 | Aligos Therapeutics公司：H.C. Wainwright发起买入评级，目标价为75美元。
Aligos Therapeutics Inc : H.c. Wainwright Initiates Coverage With Buy Rating; T...
08-19 18:15
Aligos Therapeutics Announces 1-for-25 Reverse Stock Split Effective August 19, 2024
Common Stock To Begin Trading On Nasdaq Capital Market Under Symbol ALGS With New CUSIP Number 01626L 204
08-15 21:01
快讯 | Aligos Therapeutics公司计划进行1股拆分为25股的股票逆向拆分。
Aligos Therapeutics Inc - to Effect 1-for-25 Reverse Stock Split
08-15 21:00
Oxford Nanopore Director Joins Aligos Therapeutics Board
Oxford Nanopore Technologies PLC (GB:ONT) has released an update. Heather Prest...
08-09 22:18
快讯 | Aligos therapeutics增加了两位新的独立董事。
Aligos Therapeutics Strengthens Board With Two New Independent Directors
08-09 04:05
